| Primary |
| General Anaesthesia |
22.2% |
| Tooth Disorder |
22.2% |
| Asthenia |
11.1% |
| Eosinophilic Oesophagitis |
11.1% |
| Occupational Exposure To Product |
11.1% |
| Parkinson's Disease |
11.1% |
| Product Used For Unknown Indication |
11.1% |
|
| Somnolence |
10.5% |
| Bronchospasm |
5.3% |
| Drug Dependence |
5.3% |
| Electrocardiogram Abnormal |
5.3% |
| Hypotension |
5.3% |
| Jaundice |
5.3% |
| Pancytopenia |
5.3% |
| Respiratory Disorder |
5.3% |
| Rhabdomyolysis |
5.3% |
| Rhinitis |
5.3% |
| Sinus Bradycardia |
5.3% |
| Subacute Combined Cord Degeneration |
5.3% |
| Swollen Tongue |
5.3% |
| Syncope |
5.3% |
| Tachycardia |
5.3% |
| Thermal Burn |
5.3% |
| Urine Analysis Abnormal |
5.3% |
| Vitamin B12 Decreased |
5.3% |
|
| Secondary |
| Anaesthesia |
19.7% |
| Induction Of Anaesthesia |
12.5% |
| Maintenance Of Anaesthesia |
11.1% |
| Drug Use For Unknown Indication |
10.8% |
| General Anaesthesia |
10.6% |
| Premedication |
6.0% |
| Product Used For Unknown Indication |
5.9% |
| Anaesthesia Procedure |
3.4% |
| Analgesic Therapy |
3.4% |
| Sedation |
3.4% |
| Drug Detoxification |
1.9% |
| Antibiotic Therapy |
1.6% |
| Hypertension |
1.5% |
| Primary Ciliary Dyskinesia |
1.4% |
| Muscle Relaxant Therapy |
1.3% |
| Neuromuscular Blockade |
1.3% |
| Vitamin Supplementation |
1.3% |
| Diuretic Therapy |
1.0% |
| Antibiotic Level |
0.9% |
| Blood Pressure Management |
0.9% |
|
| Nausea |
13.5% |
| Ventricular Tachycardia |
11.5% |
| Toxic Epidermal Necrolysis |
10.4% |
| Respiratory Distress |
8.3% |
| Pulseless Electrical Activity |
7.3% |
| Toxicity To Various Agents |
6.3% |
| Conversion Disorder |
4.2% |
| Hypotension |
4.2% |
| Laryngeal Oedema |
4.2% |
| Rhabdomyolysis |
4.2% |
| Somatoform Disorder |
4.2% |
| Dissociation |
3.1% |
| Drug Interaction |
3.1% |
| Unresponsive To Stimuli |
3.1% |
| Deafness Neurosensory |
2.1% |
| Pco2 Decreased |
2.1% |
| Procedural Vomiting |
2.1% |
| Renal Failure Acute |
2.1% |
| Respiratory Arrest |
2.1% |
| Respiratory Depression |
2.1% |
|
| Concomitant |
| Drug Use For Unknown Indication |
16.5% |
| Anaesthesia |
15.8% |
| Maintenance Of Anaesthesia |
15.3% |
| Induction Of Anaesthesia |
12.1% |
| General Anaesthesia |
8.5% |
| Product Used For Unknown Indication |
6.6% |
| Induction And Maintenance Of Anaesthesia |
3.5% |
| Surgery |
3.1% |
| Autism Spectrum Disorder |
1.8% |
| Irritability |
1.8% |
| Anaesthesia Procedure |
1.8% |
| Anaesthetic Premedication |
1.8% |
| Depression |
1.8% |
| Procedural Pain |
1.8% |
| Premedication |
1.7% |
| Hypertension |
1.5% |
| Hypotension |
1.4% |
| Myelitis Transverse |
1.1% |
| Pain |
1.1% |
| Fibromyalgia |
1.1% |
|
| Rhabdomyolysis |
12.0% |
| Weight Gain Poor |
10.2% |
| Ventricular Fibrillation |
6.6% |
| Obstructive Airways Disorder |
6.0% |
| Hypotension |
5.4% |
| Strabismus |
5.4% |
| Unresponsive To Stimuli |
5.4% |
| Drug Withdrawal Syndrome |
4.8% |
| Serotonin Syndrome |
4.8% |
| Long Qt Syndrome |
4.2% |
| Ventricular Tachycardia |
4.2% |
| Neuromuscular Block Prolonged |
3.6% |
| Respiratory Distress |
3.6% |
| Respiratory Failure |
3.6% |
| Torsade De Pointes |
3.6% |
| Ventricular Extrasystoles |
3.6% |
| Vomiting |
3.6% |
| Weight Decreased |
3.6% |
| Cardiovascular Insufficiency |
3.0% |
| Delayed Recovery From Anaesthesia |
3.0% |
|
